• Channels
    • All News
    • Premium Content
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Discovery
    • FDA+
    • Financing
    • In Focus
    • Manufacturing
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • About Us
    • Help
  • SIGN UP

TG Ther­a­peu­tics pre­pares to ap­proach reg­u­la­tors with MS drug; In­vestors bet $93M on a life sci­ences tools com­pa­ny

16 hours ago
News Briefing

As­traZeneca-Alex­ion merg­er slides through FTC re­view af­ter sup­posed M&A crack­down pos­es no bar­ri­ers

17 hours ago
Deals
Pharma

No­vavax CFO Greg Covi­no makes a quick ex­it as lead­er­ship carousel keeps turn­ing; Kite ex­ecs fly away to a cell ...

17 hours ago
Peer Review

Look­ing to ce­ment its lead in packed MS mar­ket, Roche's Ocre­vus un­corks new da­ta in ear­ly-stage pa­tients

18 hours ago
R&D

J&J faces CDC ad­vi­so­ry com­mit­tee again next week to weigh Covid-19 vac­cine risks

18 hours ago
Coronavirus

Opin­ion: Pfiz­er, BioN­Tech did­n't take US gov­ern­men­t's sup­port to de­vel­op their vac­cine. Let's stop rewrit­ing the ...

18 hours ago
Opinion

In high­ly un­usu­al move, Paci­ra sues med­ical jour­nal for li­bel over its non-opi­oid painkiller

19 hours ago
Pharma

Covid-19 roundup: Biden in­vests $1.7B to ad­dress Covid vari­ants; EU puts faith in Pfiz­er with new vac­cine deals

19 hours ago
Coronavirus

Os­man Kibar lays down his hand at Sa­mumed, step­ping away from CEO role as his once-her­ald­ed an­ti-ag­ing biotech ...

20 hours ago
Financing

In one of their first ever ac­qui­si­tions, Re­lay bets $85M cash on a new AI-based screen­ing ap­proach

21 hours ago
Deals

Eli Lil­ly-part­nered biotech taps star in­ves­ti­ga­tor Alan List as CMO — a year af­ter he re­signed from Mof­fitt over ...

21 hours ago
People

Eli Lil­ly asks FDA to re­voke EUA for Covid-19 treat­ment

21 hours ago
FDA+
Coronavirus

Abzena picks North Car­oli­na as the home for its 6th man­u­fac­tur­ing site, plans to add 325 jobs in San­ford

Yesterday
Outsourcing
Manufacturing

Avro­bio is us­ing 'pod­s' to cre­ate gene ther­a­pies, and it be­lieves the ap­proach could change the game al­to­geth­er

Yesterday
R&D
Manufacturing

FDA blasts Colom­bian drug man­u­fac­tur­er in warn­ing let­ter for not prop­er­ly ad­dress­ing API flaws

Yesterday
R&D
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Mod­er­na eyes Nexus' Wis­con­sin plant for vac­cine boost; Catal­ent wraps up plant ...

Yesterday
Coronavirus
Manufacturing

Ex­clu­sive: Vik Ba­jaj set out al­most 2 years ago to hatch new com­pa­nies that would shake up health­care with da­ta ...

Yesterday
Startups

Alchemab bags fresh round of in­vestor for tar­get-ag­nos­tic an­ti­body de­vel­op­ment for Hunt­ing­ton's, Covid-19

Yesterday
Financing
R&D

The world of Wnt heads to Nas­daq as Sur­rozen an­nounces a $212M SPAC deal

Yesterday
Financing

Roche touts 2-year ef­fi­ca­cy da­ta for SMA ther­a­py Evrys­di; NIH funds new net­work to study flu and virus­es with ...

Yesterday
News Briefing

PDU­FA VII to ex­pand FDA’s re­al-time on­col­o­gy re­views to sup­ple­ments for all ther­a­peu­tic ar­eas

Yesterday
FDA+

Ac­tivist in­vestor grabs a multi­bil­lion-pound stake in Glax­o­SmithK­line, trig­ger­ing buzz about a loom­ing show­down at ...

Yesterday
Bioregnum
R&D

Af­ter a ma­jor facelift, Al­tru­Bio says it's ready for a piv­otal fight against graft-ver­sus-host dis­ease

Yesterday
Financing

Glax­o­SmithK­line’s head of vac­cine R&D is jump­ing to a well­ness com­pa­ny con­cen­trat­ing on the mi­cro­bio­me as re­ports ...

Yesterday
People
1234 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Premium Content
  • Don't Miss
  • Special

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Discovery
  • FDA+
  • Financing
  • In Focus
  • Manufacturing
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints Company 2021

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
Endpoints News

Log in to your account

e-mail

password

Endpoints News

request magic link

If you're already an Endpoints subscriber, enter your email below for a magic link that lets you log in quickly without using a password. Please note the magic link is one-time use only and expires after 24 hours.

email

Endpoints News

reset password

We'll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours.

email

Endpoints News

About You

Subscriptions

ENDPOINTS NEWSby John Carroll & team — all the news at 11:30am ET

EARLY EDITIONby Arsalan Arif — news and links at 7:15am ET

ENDPOINTS MANUFACTURINGWeekly biopharma manufacturing report, Thursdays at 2pm ET

ENDPOINTS WEEKLYRecaps the most important developments on Saturday 6am ET

ENDPOINTS FDA+Regulatory news and analysis for drug developers, Wednesday 2pm ET